KRAS and colorectal cancer: Recent studies have demonstrated that thyroid hormones can promote the nuclear accumulation of HMGA2 and β-catenin in colorectal cancer cells, with varying K-RAS mutation states, in a concentration-dependent manner, ultimately facilitating cancer proliferation (15–17).